- Home
- GPCR vs PAR Comparison
GPCR vs PAR Comparison
Compare GPCR & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- PAR
- Stock Information
- Founded
- GPCR 2016
- PAR 1968
- Country
- GPCR United States
- PAR United States
- Employees
- GPCR N/A
- PAR N/A
- Industry
- GPCR
- PAR Office Equipment/Supplies/Services
- Sector
- GPCR
- PAR Miscellaneous
- Exchange
- GPCR Nasdaq
- PAR Nasdaq
- Market Cap
- GPCR 1.8B
- PAR 2.0B
- IPO Year
- GPCR 2023
- PAR N/A
- Fundamental
- Price
- GPCR $40.36
- PAR $56.09
- Analyst Decision
- GPCR Buy
- PAR Strong Buy
- Analyst Count
- GPCR 6
- PAR 7
- Target Price
- GPCR $81.33
- PAR $60.86
- AVG Volume (30 Days)
- GPCR 593.8K
- PAR 275.7K
- Earning Date
- GPCR 08-08-2024
- PAR 11-07-2024
- Dividend Yield
- GPCR N/A
- PAR N/A
- EPS Growth
- GPCR N/A
- PAR N/A
- EPS
- GPCR N/A
- PAR 0.06
- Revenue
- GPCR N/A
- PAR $425,933,000.00
- Revenue This Year
- GPCR N/A
- PAR N/A
- Revenue Next Year
- GPCR N/A
- PAR $17.48
- P/E Ratio
- GPCR N/A
- PAR $1,156.05
- Revenue Growth
- GPCR N/A
- PAR 29.65
- 52 Week Low
- GPCR $26.61
- PAR $28.21
- 52 Week High
- GPCR $75.02
- PAR $56.75
- Technical
- Relative Strength Index (RSI)
- GPCR 57.92
- PAR 67.04
- Support Level
- GPCR $38.27
- PAR $51.39
- Resistance Level
- GPCR $42.67
- PAR $53.79
- Average True Range (ATR)
- GPCR 2.29
- PAR 1.55
- MACD
- GPCR 0.31
- PAR 0.12
- Stochastic Oscillator
- GPCR 76.72
- PAR 98.38
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About PAR PAR Technology Corporation
PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.